Supernus Pharmaceuticals Inc. (SUPN)

29.42
NASDAQ : Health Technology
Prev Close 28.98
Day Low/High 28.85 / 29.75
52 Wk Low/High 25.32 / 51.38
Avg Volume 515.00K
Exchange NASDAQ
Shares Outstanding 52.45M
Market Cap 1.52B
EPS 2.10
P/E Ratio 14.79
Div & Yield N.A. (N.A)

Latest News

Supernus Pharmaceuticals Becomes Oversold (SUPN)

Supernus Pharmaceuticals Becomes Oversold (SUPN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Interesting SUPN Put And Call Options For August 16th

Interesting SUPN Put And Call Options For August 16th

Investors in Supernus Pharmaceuticals Inc saw new options become available this week, for the August 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SUPN options chain for the new August 16th contracts and identified one put and one call contract of particular interest.

10 Speculative Stock Plays in the Biotech Sector

10 Speculative Stock Plays in the Biotech Sector

For investors interested in biotech, there's a lot to choose from, with options ranging from startups with potentially blockbuster new treatments to companies those that have been around the block a few times.

Noteworthy Tuesday Option Activity: SUPN, MAXR, EROS

Noteworthy Tuesday Option Activity: SUPN, MAXR, EROS

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Supernus Pharmaceuticals Inc , where a total of 2,962 contracts have traded so far, representing approximately 296,200 underlying shares. That amounts to about 42.6% of SUPN's average daily trading volume over the past month of 695,575 shares.

3 Profitable Small Biotech Names to Consider

3 Profitable Small Biotech Names to Consider

Exelixis Inc., ANI Pharmaceuticals and Supernus Pharmaceuticals should not need to raise more capital in the foreseeable future.

Noteworthy Wednesday Option Activity: SUPN, AAC, BLDR

Noteworthy Wednesday Option Activity: SUPN, AAC, BLDR

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Supernus Pharmaceuticals Inc , where a total volume of 2,750 contracts has been traded thus far today, a contract volume which is representative of approximately 275,000 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 58.5% of SUPN's average daily trading volume over the past month, of 469,980 shares.

First Week Of November 16th Options Trading For Supernus Pharmaceuticals (SUPN)

First Week Of November 16th Options Trading For Supernus Pharmaceuticals (SUPN)

Investors in Supernus Pharmaceuticals Inc saw new options become available this week, for the November 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SUPN options chain for the new November 16th contracts and identified one put and one call contract of particular interest.

First Week Of October 19th Options Trading For Supernus Pharmaceuticals (SUPN)

First Week Of October 19th Options Trading For Supernus Pharmaceuticals (SUPN)

Investors in Supernus Pharmaceuticals Inc saw new options begin trading this week, for the October 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SUPN options chain for the new October 19th contracts and identified one put and one call contract of particular interest.

More Tax Reform Winners

More Tax Reform Winners

One way or another I continue to believe that some sort of tax legislation will be signed before the end of the year.

CVS Health, Coca-Cola, Norfolk Southern: 'Mad Money' Lightning Round

CVS Health, Coca-Cola, Norfolk Southern: 'Mad Money' Lightning Round

Jim Cramer is bullish on CVS Health, Coca-Cola, Norfolk Southern, IBM and Randgold Resources.

Victory Comes From Leadership: Cramer's 'Mad Money' Recap (Thursday 11/9/17)

Victory Comes From Leadership: Cramer's 'Mad Money' Recap (Thursday 11/9/17)

Jim Cramer says that whether it's at West Point or on Wall Street, leadership comes from loyalty, innovation, and the first-mover advantage.

MediWound Shares Lower After Pricing Stock Offering - Biotech Movers

MediWound Shares Lower After Pricing Stock Offering - Biotech Movers

MediWound priced an underwritten public offering of 4.4 million shares at $5 apiece.

Supernus Defeats Second Generic Challenger To Oxtellar XR®

Supernus Defeats Second Generic Challenger To Oxtellar XR®

Federal Court Finds Supernus Patents Valid and Infringed by TWi

UPS, McKesson, Chegg and More: 'Mad Money' Lightning Round

UPS, McKesson, Chegg and More: 'Mad Money' Lightning Round

Here's a look at what Jim Cramer had to say about companies of interest to Mad Money viewers.

TheStreet Quant Rating: C+ (Hold)